[Vaccination of individuals undergoing immunosuppressive therapy].

Protecting individuals undergoing immunosuppressive therapy through vaccination remains a clinical challenge due to the heterogeneity of underlying conditions and immunosuppressive treatments. These patients are at increased risk of severe infections, yet vaccination uptake remains suboptimal. Although vaccine responses may be reduced, this review finds vaccination to be generally safe, except for live attenuated vaccines, which should be avoided due to the risk of severe disease. A structured, multidisciplinary approach to vaccination may enhance uptake and improve protection in this vulnerable patient group.